Evidence map›Paper›PMID 33206204›Full record

ReviewCellular and molecular life sciences : CMLS2021

Human pituitary development and application of iPSCs for pituitary disease.

Ryusaku Matsumoto, Yutaka Takahashi

Open access · greenAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Progress, challenges and perspectives in the management of hypopituitarism.Reviews in endocrine & metabolic disorders · 2024
    Article
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Ryusaku MatsumotoDepartment of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, Kobe, Japan.ORCID http://orcid.org/0000-0002-7191-5326
Yutaka TakahashiDepartment of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, Kobe, Japan. takahash@naramed-u.ac.jp.ORCID http://orcid.org/0000-0002-1337-9246
Kyoto University · JPNara Medical University · JP

Funding

Japan Agency for Medical Research and Development 18bm0804012h0002Japan Society for the Promotion of Science 16H05332Japan Society for the Promotion of Science 17K19684Japan Society for the Promotion of Science 18K16232
6 · The paper itself

Abstract

The pituitary plays a pivotal role in maintaining systemic homeostasis by secreting several hormones. During fetal development, the pituitary develops from the oral ectoderm in contact with the adjacent hypothalamus. This process is regulated by the fine-tuned expression of transcription and growth factors. Impairments of this process result in congenital pituitary hypoplasia leading to dysfunction of the pituitary. Although animal models such as knockout mice have helped to clarify these underlying mechanisms, the developmental processes of the human pituitary gland and the mechanisms of human pituitary disorders have not been fully understood. This is because, at least in part, of the lack of a human pituitary developmental model. Recently, methods for in vitro induction of the pituitary gland from human pluripotent stem cells were developed. These models can be utilized not only for regenerative medicine but also for human pituitary studies on developmental biology and for modeling of pituitary disorders, such as hypopituitarism and pituitary tumors. In this review, we provide an overview of recent progress in the applications of pluripotent stem cells for pituitary research and discuss further perspectives for pituitary studies.

Indexed as

Cell DifferentiationAnimalsCell Culture TechniquesCells, CulturedHumansInduced Pluripotent Stem CellsPituitary DiseasesPituitary GlandPluripotent Stem CellsRegenerative MedicineDevelopmental biologyDisease modelingInduced pluripotent stem cellOrganoid culturePituitary development

Identifiers

PMID33206204
PMCPMC11071979
OpenAlexW3101397883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.